MCET (MultiCell Technologies) Pretax Margin %: -88.21% (As of Aug. 2015)


What is MultiCell Technologies Pretax Margin %?

MultiCell Technologies MCET -90.00% Pretax Margin % is -88.21% as of Aug. 2015.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. MultiCell Technologies's Pre-Tax Income for the three months ended in Aug. 2015 was $-0.17 Mil. MultiCell Technologies's Revenue for the three months ended in Aug. 2015 was $0.20 Mil. Therefore, MultiCell Technologies's pretax margin for the quarter that ended in Aug. 2015 was -88.21%.

The historical rank and industry rank for MultiCell Technologies's Pretax Margin % or its related term are showing as below:


MCET's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.42
* Ranked among companies with meaningful Pretax Margin % only.

MultiCell Technologies  (OTCPK:MCET) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

MultiCell Technologies Pretax Margin % Related Terms

MultiCell Technologies Pretax Margin % Historical Data

* Premium members only.

The historical data trend for MultiCell Technologies's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MultiCell Technologies Pretax Margin % Chart

MultiCell Technologies Annual Data
Trend Nov05 Nov06 Nov07 Nov08 Nov09 Nov10 Nov11 Nov12 Nov13 Nov14
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,302.02 -3,983.67 -2,773.47 -2,793.88 -1,079.59

MultiCell Technologies Quarterly Data
Nov10 Feb11 May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,666.67 -191.67 -2,333.33 37.71 -88.21

MCET vs ERGO, OPLI, GLAG: Pretax Margin % Comparison

For the Biotechnology subindustry, MultiCell Technologies's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MultiCell Technologies Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MultiCell Technologies's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where MultiCell Technologies's Pretax Margin % falls into.


MultiCell Technologies Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

MultiCell Technologies's Pretax Margin for the fiscal year that ended in Nov. 2014 is calculated as

Pretax Margin=Pre-Tax Income (A: Nov. 2014 )/Revenue (A: Nov. 2014 )
=-0.529/0.049
=-1,079.59 %

MultiCell Technologies's Pretax Margin for the quarter that ended in Aug. 2015 is calculated as

Pretax Margin=Pre-Tax Income (Q: Aug. 2015 )/Revenue (Q: Aug. 2015 )
=-0.172/0.195
=-88.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -88.21% mean?
MultiCell Technologies (MCET) has a Pretax Margin % of -88.21% as of Aug. 2015. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on MultiCell Technologies and its competitors.
Is MultiCell Technologies' Pretax Margin % too high?
MultiCell Technologies' current Pretax Margin % is -88.21%.
How does MultiCell Technologies' Pretax Margin % compare to ERGO and OPLI?
MultiCell Technologies' Pretax Margin % of -88.21% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on MultiCell Technologies and its competitors. MultiCell Technologies's current Pretax Margin % is -88.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MultiCell Technologies stock overvalued right now?
MultiCell Technologies (MCET) has a current Pretax Margin % of -88.21%. The current Pretax Margin % is -88.21%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For MultiCell Technologies (MCET), the current Pretax Margin % is -88.21% as of Aug. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MultiCell Technologies Business Description

Address 4144 North Central Expressway, Suite 600, Dallas, TX, USA, 75204
MultiCell Technologies Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and others. Its therapeutic development platform includes several patented techniques used to isolate, characterize, and differentiate stem cells from the human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor, and MDA-5 signaling. The company's medical device development platform is based on the design of a next-generation bioabsorbable stent, the Ideal BioStent, for interventional cardiology and peripheral vessel applications. All the operations are functioned within United States.